CytoReason builds comprehensive computational disease models to map disease and drug mechanisms. Their platform enables pharmaceutical and biotech companies to manage drug portfolios, prioritize programs, and compare treatments across patient populations by integrating human data for predictable drug development. This allows scientists to gain deep drug profiles and executives to have a bird's-eye view of their entire portfolio.